4.7 Article

Androgens During the Reproductive Years: What Is Normal for Women?

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 104, Issue 11, Pages 5379-5389

Publisher

ENDOCRINE SOC
DOI: 10.1210/jc.2019-01357

Keywords

-

Funding

  1. Grollo-Ruzzene Foundation [1135843]

Ask authors/readers for more resources

Objective: Whether serum androgen levels can identify women with androgen insufficiency or androgen excess is unresolved; thus, what constitutes normal remains uncertain. We sought to determine whether androgens, including 11-oxygenated C19 steroids, vary with age, menstrual cycle, or body mass index (BMI), during the reproductive years. Design and Setting: Cross-sectional study recruited from eastern Australian states. Participants: A total of 588 women, aged 18 to 39 years, who were not pregnant, lactating, or using systemic hormone therapy, with regular menstrual cycles and no previous diagnosis of polycystic ovarian syndrome. Main Outcome Measures: Sex steroids measured using liquid chromatography-tandem mass spectrometry. Results: Testosterone and androstenedione concentrations were significantly higher during the menstrual cycle mid- and luteal phases than in the early follicular phase, with median values across the cycle of 0.34 nmol/L (range, 0.04 to 1.01) and 1.97 nmol/L (range, 0.53 to 7.89), respectively. No cyclical variations were found in dehydroepiandrosterone (DHEA; 4.91 nmol/L; range, 0.08 to 23.51), 11-ketoandrostenedione (11KA; 7.99 nmol/L; range, 0.07 to 31.67), or 11-ketotestosterone (11KT; 1.27 nmol/L; range, 0.03 to 7.61). Overweight women had lower median testosterone (P < 0.05), DHEA (P < 0.05), and 11KA (P < 0.01) levels than normal-weight women. All C19 steroids were significantly lower (P < 0.01) in those aged 35 to 39 years than in those aged 18 to 25 years. The median 11KA/androstenedione (4.3:1) and 11KT/testosterone (3.9:1) ratios did not change with age, after adjustment for BMI and cycle stage. Conclusions: We have demonstrated that 11KA and 11KT are stable across the menstrual cycle and make major quantitative contributions to the circulating androgen pool. All C19 androgens declined with age before menopause; hence, age-specific reference ranges are required for the interpretation of androgen levels in premenopausal women.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Obstetrics & Gynecology

Association between testosterone and cognitive performance in postmenopausal women: a systematic review of observational studies

F. Sultana, S. R. Davis, R. J. Bell, S. Taylor, R. M. Islam

Summary: The association between endogenous testosterone blood concentrations and cognitive performance among postmenopausal women remains inconclusive due to the imprecision of testosterone measurement and the methodological heterogeneity of the included studies.

CLIMACTERIC (2023)

Article Obstetrics & Gynecology

Estrone, sex hormone binding globulin and lipid profiles in older women: an observational study

Z. N. Azene, S. R. Davis, J. J. McNeil, A. M. Tonkin, D. J. Handelsman, R. M. Islam

Summary: This study investigated the association between estrone and sex hormone binding globulin (SHBG) concentrations with lipid concentrations in older postmenopausal women. The results showed that estrone and SHBG are associated with lipid concentrations in older women, with SHBG providing additional clinical predictive utility for the assessment of cardiometabolic disease risk.

CLIMACTERIC (2023)

Review Obstetrics & Gynecology

Testosterone for women: certainties and uncertainties

S. R. Davis

Summary: This article summarizes some of the known information about testosterone in women, including its actions, consequences of depletion and replacement. It is not a comprehensive review of the literature in this field, but provides some informative insights.

CLIMACTERIC (2023)

Article Obstetrics & Gynecology

Sex hormones, SHBG and cognitive performance among older Australian women: an observational study

F. Sultana, S. R. Davis, A. M. Murray, R. L. Woods, J. J. McNeil, R. M. Islam

Summary: This study aimed to explore the associations between sex hormones and cognitive performance in older women. The results showed no associations between sex hormones and cognitive performance, but a correlation was found between low sex hormone binding globulin concentrations and better processing speed.

CLIMACTERIC (2023)

Letter Obstetrics & Gynecology

Author's response

S. R. Davis

CLIMACTERIC (2023)

Review Endocrinology & Metabolism

Endogenous testosterone concentrations and muscle mass, strength and performance in women, a systematic review of observational studies

Sasha Taylor, Rakibul M. Islam, Robin J. Bell, Chandima Hemachandra, Susan R. Davis

Summary: This study aims to investigate the associations between endogenous testosterone blood concentrations and muscle mass, strength, and performance in community dwelling women. The review found that there is no association between total testosterone and muscle mass, strength, or performance in women. Although calculated free or bioavailable testosterone showed a positive association with lean muscle mass, no association was found for muscle strength or performance.

CLINICAL ENDOCRINOLOGY (2023)

Article Obstetrics & Gynecology

The impact of endometriosis on work ability in young Australian women

Robin J. Bell, Penelope J. Robinson, Marina A. Skiba, Rakibul M. Islam, Chandima Hemachandra, Susan R. Davis

Summary: A large-scale study found that endometriosis has a significant impact on sick leave and work ability in women, including those without severe symptoms.

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2023)

Review Obstetrics & Gynecology

Menopause symptoms, sexual dysfunctions and pelvic floor disorders in refugee and asylum seeker women: a scoping review

M. Jahangirifar, E. Fooladi, S. R. Davis, R. M. Islam

Summary: Refugee and asylum seeker women at midlife and beyond face various health challenges, including menopausal symptoms, sexual dysfunctions, and pelvic floor disorders. However, there is limited global knowledge about the prevalence and risk factors of these neglected health issues in this population.

CLIMACTERIC (2023)

Article Endocrinology & Metabolism

The association between sex hormones and the change in brain-predicted age difference in older women

Jo Wrigglesworth, Ian H. Harding, Rakibul M. Islam, Phillip G. D. Ward, Robyn L. Woods, Robin J. Bell, John J. McNeil, Elsdon Storey, Gary Egan, Anne M. Murray, Ruth E. Trevaks, Stephanie A. Ward, Susan R. Davis, Joanne Ryan

Summary: This study investigated the relationship between circulating sex hormones and structural brain ageing in older women. The findings showed that women with higher levels of DHEA had higher baseline brain ageing, but this association was not significant after controlling for age and other potential confounding factors. Estrone, testosterone, and sex-hormone binding globulin were not associated with brain ageing. Further studies on circulating sex hormones and brain health in postmenopausal women are needed.

CLINICAL ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Hormones and Aging: An Endocrine Society Scientific Statement

Anne R. Cappola, Richard J. Auchus, Ghada El-Hajj Fuleihan, David J. Handelsman, Rita R. Kalyani, Michael McClung, Cynthia A. Stuenkel, Michael O. Thorner, Joseph G. Verbalis

Summary: Multiple changes occur in various endocrine systems as individuals age. The understanding of age-related changes and their clinical management is developing. This statement reviews the current research in different endocrine axes and conditions specific to older individuals, including available therapies, clinical trials, key points, and scientific gaps. The goal is to inform future research to improve prevention and treatment strategies for age-associated endocrine conditions in older individuals.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Medicine, General & Internal

Advancing menopause care in Australia: barriers and opportunities

Susan R. Davis, Karen Magraith

MEDICAL JOURNAL OF AUSTRALIA (2023)

Article Endocrinology & Metabolism

Thyroid Hormone Abuse Among Elite Athletes

David J. Handelsman, Matti Gild, Roderick Clifton-Bligh, Naomi Speers, Dorothy Kouzios, Melissa C. McMartin, Reena Desai

Summary: This study investigated the prevalence of thyroid hormone (TH) abuse among Australian athletes undergoing antidoping tests for WADA-compliant sports. The results showed that only 4 per 1000 athletes had biochemical thyrotoxicosis, and the prevalence of TH usage based on the doping control forms was also 4 per 1000 athletes. These estimates were consistent with international competition data and lower than the estimated T4 prescription rates in the age-matched Australian population.

JOURNAL OF THE ENDOCRINE SOCIETY (2023)

Article Endocrinology & Metabolism

Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study

David J. Handelsman, Mathis Grossmann, Bu B. Yeap, Bronwyn G. A. Stuckey, Nandini Shankara-Narayana, Ann J. Conway, Warrick J. Inder, Robert Mclachlan, Carolyn Allan, Alicia J. Jenkins, David Jesudason, Karen Bracken, Gary A. Wittert

Summary: The T4DM study shows that testosterone treatment for men with impaired glucose tolerance or newly diagnosed diabetes reduces the risk of diabetes and improves sleep apnea diagnosis during the study period, but these effects disappear after the study. There is also evidence of androgen dependence in some men receiving prolonged injectable testosterone treatment.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Andrology

Testicular function after non-cytotoxic and immunotherapy drug treatment

David J. Handelsman, Amanda Idan, Sue Sleiman, Fey Bacha, Georgina V. Long, Alexander M. Menzies, Tejnei Vaishnav, Noosha Litkouhi, Xanthie Volckmar, William Ledger, Antoinette Anazodo

Summary: The effects of non-cytotoxic and immunotherapy drugs on human testicular function in cancer patients have not been systematically studied. This study aimed to investigate the effects of these drugs in cancer patients who had not undergone gonadotoxic treatment. The results showed that non-cytotoxic and immunotherapy drugs moderately affected testicular exocrine function (sperm production) and its hormonal correlates (follicle-stimulating hormone, inhibin B), but had minimal impact on testicular endocrine function (testosterone, luteinizing hormone).

ANDROLOGY (2023)

No Data Available